Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Promoter molecule capable of specifically recognizing proliferative endothelial cells and engineering cells

A technique for activating molecules and endothelial cells, applied in the field of bioengineering, can solve the problems of identifying new blood vessels that have not been reported, and achieve the effect of improving specificity

Pending Publication Date: 2021-03-12
AFFILIATED HUSN HOSPITAL OF FUDAN UNIV +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] In the prior art, there is no report on the use of synthetic Notch system to identify new blood vessels

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Promoter molecule capable of specifically recognizing proliferative endothelial cells and engineering cells
  • Promoter molecule capable of specifically recognizing proliferative endothelial cells and engineering cells
  • Promoter molecule capable of specifically recognizing proliferative endothelial cells and engineering cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Embodiment 1 A preparation method of synNotch engineered endothelial progenitor cells, comprising the following steps:

[0060] 1) Preparation of endothelial progenitor cells

[0061] Take a C57 / BL6J mouse with a pregnancy period of 14-18 days, put the pregnant uterus in pre-cooled PBS containing 500-1000U of penicillin and streptomycin, soak for 3-5min, take out the fetal mouse, wash it twice with PBS; take it out under a microscope Fetal lung tissue was placed in PBS and shredded into small cubes with a diameter of about 1 mm.

[0062] Add 0.25% trypsin to the fetal lung tissue, culture in DMEM medium with 10% FBS for 16h-24h, centrifuge at 1500rpm for 5 minutes, discard the supernatant, take its precipitate, and use 5ml of EBM containing growth factor and 5%FBS serum- 2 medium to suspend cells to 10 6 / ml cells inoculated on T25cm 2 Cell culture flasks were cultured in a constant temperature incubator with 5% carbon dioxide at 37°C. When the growth and confluence...

Embodiment 2

[0078] Example 2 Co-cultivation of engineered cells and Apj-positive endothelial cells

[0079] 1. Isolation and culture of endothelial cells

[0080] Take the fresh umbilical cord of the postpartum mouse, cut off a 0.5 cm long section with surgical scissors; inject PBS solution into the umbilical vein, wash the residual blood; fill the umbilical vein with 0.1% collagenase, and digest it at room temperature for 5 minutes; Transfer the digestion solution containing endothelial cells to a 15ml centrifuge tube, centrifuge at 1000rpm for 5 minutes, discard the supernatant, add enough 1640 culture medium to resuspend, inoculate into a T25 culture bottle and culture for 2-3 days, the cells grow to 80- Passage at 90% confluence to obtain endothelial cells.

[0081] 2. Transfection and co-culture

[0082] Transfect the CMV promoter molecule, TRE and Sphk1-Mfsd2a gene into the prepared endothelial progenitor cells. When the promoter molecule binds to Apj, tTA will detach from the cel...

Embodiment 3

[0085] Example 3 Engineered cells identify neovascularization after traumatic brain injury

[0086] (1) Construction of traumatic brain injury model

[0087] The mice were anesthetized by intraperitoneal injection of pentobarbital sodium (0.4mg / 10g), fixed on the stereotaxic injection apparatus, and then a hole with a diameter of about 5 mm was opened in the right parietal cortex with the central suture The lines are adjacent. Then a transducing metal rod with a diameter of 2.5 mm was placed on the skull opening, and a 5-gram gravity hammer was released from a height of 15 cm to make it fall freely and hit the transducing metal rod vertically.

[0088] (2) Simultaneous transfection of promoter molecules, transcriptional response element TRE, and red fluorescent protein RFP into endothelial progenitor cells;

[0089] (3) On the 3rd day after the TBI mouse model was successfully established, the engineered cells transformed from endothelial progenitor cells were injected into ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a promoter molecule capable of specifically recognizing proliferative endothelial cells and engineering cells, which are fusion proteins and are obtained by fusing human-derived apelin, intra-membrane hydrolysable polypeptide and a deoxyribonucleic acid sequence corresponding to an effector. The intra-membrane hydrolysable polypeptide is a minimum transmembrane core structural domain of natural Notch, and the intra-membrane hydrolyzed polypeptide is partially or completely covered by the adjacent apelin and effector in a resting state. The promoter molecule has the characteristic of high functional modularization, and can be used for recognizing endothelial cells in a proliferation state, the human-derived apelin is combined with a molecular marker Apj receptor onthe surface of a new blood vessel, a cleavage site is recognized and hydrolyzed, the new blood vessel can be specifically recognized, then the expression of a set gene is regulated and controlled, andthe promoter molecule can be used for tracing the proliferative endothelial cells, and indicating the occurrence of vascular remodeling in adults, and can also be used as a treatment means to realizethe repair of the blood brain barrier.

Description

technical field [0001] The invention belongs to the field of bioengineering, and in particular relates to a promoter molecule capable of specifically recognizing proliferative endothelial cells and engineering cells. Background technique [0002] Traumatic brain injury (TBI) damage to the brain is divided into two stages: direct injury and secondary injury. Direct injury refers to the destruction of brain tissue caused by external mechanical force, leading to the destruction of tissue structure, and the direct death of cells after a devastating blow, which also includes vascular injury, bleeding, etc. Secondary injury is due to the breakdown of the homeostasis of brain tissue, especially cerebral hemorrhage, and the destruction of the blood-brain barrier, which leads to the accumulation of peripheral immune cells, secondary inflammation, and finally leads to the spread of damage and the expansion of tissue necrosis. [0003] Dysfunction of the blood-brain barrier will cause...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N5/10C12N5/071C12N15/867
CPCC12N5/069C12N15/86C07K14/47C07K2319/50C12N2740/15043C12N2510/00
Inventor 朱剑虹王智富钟俊杰陈柯竹李天文
Owner AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com